Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

57 trials with published results (11%)

Research Maturity

306 completed trials (60% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.9%

15 terminated out of 514 trials

Success Rate

95.3%

+8.8% vs benchmark

Late-Stage Pipeline

31%

160 trials in Phase 3/4

Results Transparency

19%

57 of 306 completed with results

Key Signals

57 with results95% success15 terminated

Data Visualizations

Phase Distribution

430Total
Not Applicable (148)
Early P 1 (2)
P 1 (71)
P 2 (49)
P 3 (87)
P 4 (73)

Trial Status

Completed306
Unknown103
Recruiting39
Withdrawn18
Not Yet Recruiting17
Terminated15

Trial Success Rate

95.3%

Benchmark: 86.5%

Based on 306 completed trials

Clinical Trials (514)

Showing 20 of 20 trials
NCT04200937Enrolling By InvitationPrimary

IT Matters: The Erectile Restoration Registry

NCT07642505Phase 4RecruitingPrimary

L-Citrulline and Tadalafil for Mild to Moderate Erectile Dysfunction

NCT07460167Not ApplicableCompletedPrimary

Penile Rehabilitation in Patients With Erectile Dysfunction After Pelvic Fracture Urethral Injury Using Low-intensity Shock Wave.

NCT07451808Not ApplicableNot Yet RecruitingPrimary

Male Pelvic Floor Muscle Rehabilitation Exercises

NCT07627477Active Not Recruiting

Impact of Depression Severity on Sexual Dysfunction

NCT05048667Phase 1CompletedPrimary

Shockwave Therapy and Platelet Rich Plasma for the Treatment of Erectile Dysfunction

NCT07602608Phase 4CompletedPrimary

Platelet-Rich Plasma With or Without Tadalafil for Erectile Dysfunction

NCT07592533Not ApplicableRecruitingPrimary

A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction

NCT07537855Phase 2Not Yet RecruitingPrimary

Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile Dysfunction

NCT06433596Not ApplicableActive Not RecruitingPrimary

Autologous PRP and Focal Shock Waves for Erectile Dysfunction

NCT07574268Phase 4CompletedPrimary

Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial

NCT07563647Phase 4CompletedPrimary

Association Between Diastolic Dysfunction and Erectile Dysfunction and the Effect of Tadalafil and SGLT2 Inhibitors on Them in Men With Metabolic Syndrome

NCT00582231Completed

Penile Injection Anxiety

NCT07544537Phase 2Active Not RecruitingPrimary

A Prospective Comparative Study of Autologous Bone Marrow-Derived and Adipose Tissue-Derived Mesenchymal Stem Cells Versus Platelet-Rich Plasma and Standard Therapy in Patients With Organic Erectile Dysfunction

NCT02706561Not ApplicableRecruiting

Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

NCT07048314Phase 1Not Yet RecruitingPrimary

Stem Cells for Erectile Dysfunction Post RALP

NCT03596047Not ApplicableCompletedPrimary

Radial Shockwave Therapy for Erectile Dysfunction

NCT06397612Not ApplicableActive Not Recruiting

Efficacy of Low-dose Percutaneous Electrical Stimulation in Patients With Erectile Dysfunction.

NCT07442396Not ApplicableRecruitingPrimary

The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation

NCT07431008RecruitingPrimary

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

Scroll to load more

Research Network

Activity Timeline